Lipodystrophy is a collective term used to describe a bunch of heterogeneous conditions associated with body fat and predisposition to metabolic illnesses such as ...

Novelion Therapeutics’ Myalepta (metreleptin) developed for the ultra-rare condition lipodystrophy has been approved by the European Commission, giving patients the first treatment to improve their ...

Notable companies such as Regeneron Pharmaceuticals, Ionis Pharmaceuticals, Pfizer, Amunix, Zydus Cadila, Galmed Pharmaceuticals, Cell Praxis, Carmot Therapeutics, CombiGene and others are developing ...

With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...

Aegerion Pharmaceuticals’ Myalepta, a treatment for the ultra-rare condition lipodystrophy, has been approved by the EC as an adjunct to diet as a replacement therapy to treat the complications of ...

SAN DIEGO — Drug maker Amylin Pharmaceuticals has submitted the first of a series of sections of a regulatory approval application for a biotech drug to treat patients with a rare lipid disorder.

With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...

HIV-associated lipodystrophy can cause visible changes in the way your body stores fat. It’s not an official diagnosis but rather a group of changes that some people with HIV may experience. This ...

SEATTLE, March 17, 2021, (PHARMIWEB) — HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from ...

"Lipodystrophy Syndrome Market Insight, Epidemiology and Market Forecast - 2032"The lipodystrophy syndrome market is experiencing significant expansion, driven by increasing disease awareness, rising ...